These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23124483)

  • 1. Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer.
    Hao XD; Yang Y; Song X; Zhao XK; Wang LD; He JD; Kong QP; Tang NL; Zhang YP
    Oncol Rep; 2013 Jan; 29(1):226-36. PubMed ID: 23124483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations.
    Denisov EV; Sukhanovskaya TV; Dultseva TS; Malinovskaya EA; Litviakov NV; Slonimskaya EM; Choinzonov EL; Cherdyntseva NV
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):901-7. PubMed ID: 21810023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
    N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
    Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
    Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
    Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
    Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer.
    Kyndi M; Alsner J; Hansen LL; Sørensen FB; Overgaard J
    Acta Oncol; 2006; 45(5):602-9. PubMed ID: 16864176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer.
    Naccarati A; Polakova V; Pardini B; Vodickova L; Hemminki K; Kumar R; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):211-8. PubMed ID: 22294769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
    Olivier M; Langerød A; Carrieri P; Bergh J; Klaar S; Eyfjord J; Theillet C; Rodriguez C; Lidereau R; Bièche I; Varley J; Bignon Y; Uhrhammer N; Winqvist R; Jukkola-Vuorinen A; Niederacher D; Kato S; Ishioka C; Hainaut P; Børresen-Dale AL
    Clin Cancer Res; 2006 Feb; 12(4):1157-67. PubMed ID: 16489069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age.
    Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z
    Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 and oesophageal cancer.
    Ferec C; Giroux MA; Audrezet MP; Robaszkiewicz M
    Pathol Biol (Paris); 1997 Dec; 45(10):871-5. PubMed ID: 9769951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
    Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation.
    Cardin R; Piciocchi M; Tieppo C; Maddalo G; Zaninotto G; Mescoli C; Rugge M; Farinati F
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S583-9. PubMed ID: 23744553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients.
    Gochhait S; Bhatt A; Sharma S; Singh YP; Gupta P; Bamezai RN
    Int J Cancer; 2008 Dec; 123(11):2580-6. PubMed ID: 18792899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
    Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
    Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different TP53 mutations are associated with specific chromosomal rearrangements, telomere length changes, and remodeling of the nuclear architecture of telomeres.
    Samassekou O; Bastien N; Lichtensztejn D; Yan J; Mai S; Drouin R
    Genes Chromosomes Cancer; 2014 Nov; 53(11):934-50. PubMed ID: 25059482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions.
    Chene G; Tchirkov A; Pierre-Eymard E; Dauplat J; Raoelfils I; Cayre A; Watkin E; Vago P; Penault-Llorca F
    Clin Cancer Res; 2013 Jun; 19(11):2873-82. PubMed ID: 23589176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.
    Neves Filho EH; Cordeiro DE; Vieira AP; Rabenhorst SH
    Pathobiology; 2012; 79(6):323-8. PubMed ID: 22688387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.